NCT05300568View on ClinicalTrials.gov

A Survey About Trade-offs When Choosing Menopause Treatments

CompletedOBSERVATIONAL

Enrollment

1,465

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

August 27, 2023

Study Completion Date

August 27, 2023

Conditions

Moderate to Severe Vasomotor Symptoms

Interventions

OTHER

No Intervention

This is a non-product related survey.

Trial Locations (1)

Unknown

Site GB44001, Hammersmith

All Listed Sponsors

lead

Astellas Pharma Europe Ltd.

INDUSTRY